News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,616 Results
Type
Article (1399)
Company Profile (12)
Press Release (67205)
Section
Business (31936)
Career Advice (47)
Deals (4693)
Drug Delivery (1)
Drug Development (7455)
Employer Resources (5)
FDA (1427)
Job Trends (1590)
News (43394)
Policy (2300)
Tag
Academia (132)
Accelerated approval (1)
Allergies (15)
Alliances (2652)
ALS (5)
Alzheimer's disease (188)
Antibody-drug conjugate (ADC) (9)
Approvals (1450)
Artificial intelligence (14)
Autoimmune disease (3)
Bankruptcy (31)
Best Places to Work (1547)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (8)
Bladder cancer (20)
Brain cancer (1)
Breast cancer (39)
Cancer (249)
Cardiovascular disease (19)
Career advice (43)
Career pathing (1)
CAR-T (5)
Cell therapy (37)
Cervical cancer (3)
Clinical research (6621)
Collaboration (50)
Compensation (19)
Complete response letters (3)
COVID-19 (130)
CRISPR (3)
C-suite (6)
Cystic fibrosis (7)
Data (334)
Depression (4)
Diabetes (32)
Diagnostics (635)
Digital health (2)
Diversity, equity & inclusion (3)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (7)
Earnings (27705)
Employer resources (5)
Events (9012)
Executive appointments (21)
FDA (1654)
Frontotemporal dementia (1)
Funding (42)
Gene editing (7)
Gene therapy (30)
GLP-1 (52)
Government (239)
Guidances (85)
Healthcare (2026)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (10)
Indications (3)
Infectious disease (141)
Inflammatory bowel disease (6)
Influenza (4)
Intellectual property (11)
Interviews (4)
IPO (3524)
IRA (1)
Job creations (132)
Job search strategy (40)
Labor market (2)
Layoffs (15)
Leadership (2)
Legal (390)
Liver cancer (5)
Lung cancer (33)
Lymphoma (34)
Manufacturing (15)
MASH (9)
Medical device (2094)
Medtech (2094)
Mergers & acquisitions (1204)
Metabolic disorders (69)
Multiple sclerosis (22)
NASH (3)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (258)
NextGen: Class of 2025 (551)
Non-profit (258)
Obesity (31)
Opinion (2)
Ovarian cancer (8)
Pain (6)
Pancreatic cancer (5)
Parkinson's disease (25)
Patents (19)
Patient recruitment (11)
Peanut (14)
People (2439)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (1535)
Phase II (2666)
Phase III (2832)
Pipeline (509)
Policy (3)
Postmarket research (254)
Preclinical (490)
Press Release (4)
Prostate cancer (10)
Radiopharmaceuticals (25)
Rare diseases (32)
Real estate (281)
Recruiting (3)
Regulatory (1848)
Reports (7)
Research institute (119)
Resumes & cover letters (2)
Rett syndrome (2)
RSV (5)
Schizophrenia (10)
Series A (9)
Series B (4)
Service/supplier (1)
Sickle cell disease (5)
Special edition (2)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (117)
Stomach cancer (1)
Supply chain (4)
Vaccines (48)
Venture capitalists (2)
Weight loss (13)
Date
Last 7 days (230)
Last 30 days (492)
Last 365 days (4540)
2025 (1767)
2024 (4715)
2023 (5356)
2022 (6384)
2021 (7213)
2020 (6571)
2019 (5329)
2018 (3995)
2017 (3480)
2016 (2481)
2015 (3651)
2014 (2599)
2013 (1425)
2012 (1526)
2011 (1758)
2010 (1504)
Location
Africa (43)
Alabama (3)
Arizona (9)
Asia (3114)
Australia (377)
California (829)
Canada (281)
China (33)
Colorado (44)
Connecticut (41)
Delaware (23)
Europe (8312)
Florida (122)
Georgia (57)
Idaho (8)
Illinois (110)
India (2)
Indiana (52)
Iowa (3)
Japan (13)
Kansas (8)
Kentucky (1)
Louisiana (4)
Maine (33)
Maryland (121)
Massachusetts (539)
Michigan (85)
Minnesota (64)
Missouri (7)
Montana (3)
Nevada (10)
New Hampshire (11)
New Jersey (317)
New York (341)
North Carolina (179)
North Dakota (2)
Northern California (402)
Ohio (26)
Oklahoma (1)
Oregon (3)
Pennsylvania (186)
Rhode Island (1)
South America (83)
South Carolina (3)
Southern California (328)
Tennessee (7)
Texas (141)
United States (3459)
Utah (34)
Virginia (10)
Washington D.C. (6)
Washington State (100)
Wisconsin (5)
68,616 Results for "84".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales
May 9, 2025
·
13 min read
Press Releases
Vizient Forecasts a 3.84% Rise in Pharmacy Spending
January 28, 2025
·
5 min read
Press Releases
U.S. Pharmaceutical CDMO Market Size to Surpass USD 84.33 Bn by 2034
February 25, 2025
·
1 min read
Press Releases
Single-Use Bioprocessing Market to Worth USD 146.84 Billion by 2034
February 7, 2025
·
1 min read
BioMidwest
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
Veru Inc. announced that the Company will present two presentations at the American Diabetes Association’s 84th Scientific Sessions, taking place June 21-24, 2024, in Orlando, Florida.
June 10, 2024
·
10 min read
FDA
SpliSense Receives FDA Fast Track Designation for SPL84 for the Treatment of Cystic Fibrosis
SpliSense today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to SPL84 for CF.
May 29, 2024
·
3 min read
Rare diseases
Abeona Gets FDA Nod for Rare Skin Disease Gene Therapy
The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.
April 29, 2025
·
1 min read
·
Dan Samorodnitsky
Biotech Bay
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA’s 84th Scientific Sessions
Innovent Biologics, Inc. announces that it will present multiple clinical study results of mazdutide at the American Diabetes Association’s® 84th Scientific Sessions in Orlando from June 21 -24.
June 11, 2024
·
5 min read
Press Releases
Autism Spectrum Disorder Markets Expected to Exhibit a CAGR Of 5.84% During 2025-2035, impelled by Innovative Treatments
February 13, 2025
·
10 min read
Osteoarthritis Market Size, Trends and Companies Report | 8.4% - CAGR Growth by 2032
The global osteoarthritis market size was valued at USD 8.60 billion in 2023 and is poised to grow from USD 9.26 billion in 2024 to reach around USD 19.15 billion by 2032, at a CAGR of 8.4% during the forecast period 2023-2032.
June 27, 2024
·
13 min read
1 of 6,862
Next
